BioRem Past Earnings Performance

Past criteria checks 6/6

BioRem has been growing earnings at an average annual rate of 28.6%, while the Commercial Services industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 7.4% per year. BioRem's return on equity is 52.2%, and it has net margins of 12.9%.

Key information

28.6%

Earnings growth rate

48.3%

EPS growth rate

Commercial Services Industry Growth7.3%
Revenue growth rate7.4%
Return on equity52.2%
Net Margin12.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

Apr 19
Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

Recent updates

Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Oct 11
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

Apr 19
Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

Apr 12
BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Jan 25
BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Is BioRem (CVE:BRM) Using Too Much Debt?

Aug 26
Is BioRem (CVE:BRM) Using Too Much Debt?

Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

Mar 23
Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

BioRem (CVE:BRM) Could Easily Take On More Debt

Aug 25
BioRem (CVE:BRM) Could Easily Take On More Debt

These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

May 20
These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Jan 26
Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Nov 23
Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Revenue & Expenses Breakdown

How BioRem makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:BRM Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2440560
30 Jun 2431440
31 Mar 2428340
31 Dec 2325240
30 Sep 2324150
30 Jun 2326160
31 Mar 2328160
31 Dec 2229260
30 Sep 2229250
30 Jun 2226240
31 Mar 2225240
31 Dec 2124140
30 Sep 2122150
30 Jun 2121140
31 Mar 2121150
31 Dec 2024250
30 Sep 2021-150
30 Jun 2023-160
31 Mar 2023-160
31 Dec 1921-160
30 Sep 1927560
30 Jun 1925550
31 Mar 1925550
31 Dec 1824550
30 Sep 1822140
30 Jun 1823240
31 Mar 1823140
31 Dec 1723240
30 Sep 1719140
30 Jun 1718040
31 Mar 1715040
31 Dec 1616130
30 Sep 1614130
30 Jun 1615130
31 Mar 1616240
31 Dec 1517240
30 Sep 1518240
30 Jun 1516141
31 Mar 1513-131
31 Dec 1411-231
30 Sep 1412-131
30 Jun 1415-141
31 Mar 1417041
31 Dec 1320141

Quality Earnings: BRM has high quality earnings.

Growing Profit Margin: BRM's current net profit margins (12.9%) are higher than last year (2.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BRM's earnings have grown significantly by 28.6% per year over the past 5 years.

Accelerating Growth: BRM's earnings growth over the past year (711.5%) exceeds its 5-year average (28.6% per year).

Earnings vs Industry: BRM earnings growth over the past year (711.5%) exceeded the Commercial Services industry 14.5%.


Return on Equity

High ROE: BRM's Return on Equity (52.2%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies